[1] Uygur-Bayramicli O, Dabakr, Orbaye, E, et al. Type 2 diabetes mellitus and CA199 levels[J].World J Gastroenterol,2007,13(40):5357-5359. [2] Ben Q,Cai Q,Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk, a case-control study[J].Eur J Cancer,2011,47 (2),248-254. [3] 曹晶晶,彭俊华,殷瑞鹏,等.影响糖化血红蛋白HbA1c检测结果的因素分析[J].现代检验医学杂志,2012.27(5):75-76. [4] Morris-Stiff G,Teli M,Jardine N,et al. CAl99 antigen levels can distinguish between benign and malignant pancreaticobiliary disease[J]. Hepatobiliary Pancreat Dis Int,2009(8):620-626. [5] 徐美华,张桂英,张鹏.CAl25在结核性腹膜炎患者中的临床意义[J]. 世界华人消化杂志,2005,13(9):1156-1157. [6] Benhamou PY,Vuilles JP, Halimi S, et al. Influence of metabolic disturbances of diabetes mellitus onserum CA199 tumor marker[J]. Diabete Metab,1991,17(1):39-43. [7] 许成新,成世勇,沈树标,等. 996例糖类抗原CAl99阳性者临床检验分析[J].中国现代临床医学杂志,2008,7(2):28-29. [8] 申小英,马丽娜,俞孝芳,等.2型糖尿病患者血清CAl99水平的观察分析[J]. 现代实用医学,2009,12(12):1291-1334. [9] 何双涛,刘军,周连华.2型糖尿病患者血糖、胰岛素抵抗和B细胞功能对CA199水平的影响.中国糖尿病杂志,2012,20(7): 493-495. [10] 于永浩,包玉倩,张磊,等.住院糖尿病患者CA199水平与血糖控制程度的关系[J].中华医学杂志, 2010,90(6):394-395. [11] 彭敏,黄平.血糖波动与CA19-9水平变化的相关性研究进展[J].浙江临床医学,2009,11(6),644-646. [12] 赵琪,黄学文.糖尿病患者血清中CA19-9水平与唾液酸及Lewis血型的关系[J].临床检验杂志,2008,26(2):137-139. [13] Gul K,Nas S,Ozdemir D,et al. CA199 level in patients with tupe 2 diabetes mellitus and its relation to the metabolic control and microvascular complications[J]. Am J Med Sci,2011,341(1):28-32. [14] 陈灏珠.实用内科学[M]. 12 版.北京:人民卫生出版社,2005:1022. [15] 韦华,王民登.糖尿病与肿瘤关系研究现状[J].中外医学研究,2011,9(22):155-157. [16] Chang CK,Ulrich CM.Hyperinsulinaemia and hyperglycaemia:possible risk factors of colorectal cancer among diabetic patients [J].Diabetologia,2003,46(5):595-607. [17] Rendhan A,Smith U,Kirkman MS.Linking diabetes and cancer:a consensus on complexity[J]. Lancet,2110(375):2201-2202. |